Switch from zidovudine- to non-zidovudine-containing regimens is associated with modest haematological improvement and no obvious clinical benefit: a substudy of the ANRS 099 ALIZE trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples